News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Gilead Sciences, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Drug Development
Gilead Sciences, Inc.'s Experimental Drug Simtuzumab Fails Mid-Stage Study
September 17, 2014
·
2 min read
Biotech Bay
Retrophin, Inc., Gilead Sciences, Inc., And Our Healthcare Values
September 15, 2014
·
1 min read
Business
Gilead Sciences, Inc. Says Indian Firms May Sell Generics of Hep C Drug Sovaldi
September 15, 2014
·
2 min read
Business
Gilead Sciences, Inc., “The New Genentech,” Remaps Massive Foster City Campus
August 29, 2014
·
2 min read
Deals
Achillion Pharmaceuticals, Inc. Hits One Year High After Rumors Gilead Sciences, Inc. Might Buy It Out
August 27, 2014
·
2 min read
Drug Development
Gilead Sciences, Inc. Shaky As Achillion Pharmaceuticals, Inc.'s Hepatitis C Drug Cures All Patients In Mid-Stage Trial
August 15, 2014
·
2 min read
Biotech Bay
Gilead Sciences, Inc. Popular Amongst Latest 13F Filers
July 31, 2014
·
1 min read
Biotech Bay
Politicizing Gilead Sciences, Inc.'s R&D Solvadi Costs Is A Reckless And Dangerous Misadventure
July 28, 2014
·
1 min read
Business
4 Ways Gilead Sciences, Inc.’s Earnings Will Impact Every American
July 24, 2014
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Gilead’s Head Of Commercial Operations To Step Down
January 7, 2014
·
1 min read
Business
Gilead Sciences, Inc.’ Kevin Young CBE, Executive Vice President, Commercial Operations, To Retire
January 7, 2014
·
1 min read
Drug Development
Gilead Sciences, Inc. Offers Strong Phase 3 Data on Hepatitis C Treatment, Plans Application
December 18, 2013
·
1 min read
Biotech Bay
Health Canada Issues Notice Of Compliance For Gilead Sciences, Inc.'s Sovaldi™ (Sofosbuvir) For The Treatment Of Chronic Hepatitis C
December 16, 2013
·
1 min read
FDA
FDA Approves Gilead Sciences, Inc.'s Once-Daily Single Tablet HIV-1 Regimen
December 16, 2013
·
10 min read
Drug Development
Gilead Sciences, Inc. Announces Interim Phase 2 Results For GS-9973 In Previously Treated Chronic Lymphocytic Leukemia
December 9, 2013
·
1 min read
Drug Development
Gilead Sciences, Inc. Announces Pivotal Phase 2 Data For Idelalisib In Refractory Indolent Non-Hodgkin’s Lymphoma
December 9, 2013
·
1 min read
FDA
FDA Approves Gilead Sciences, Inc.'s Sovaldi, A $1,000-A-Day Hepatitis C Pill
December 9, 2013
·
11 min read
Biotech Bay
Gilead Sciences, Inc. To Present At The NASDAQ OMX 30th Investor Program On Tuesday, December 3
December 3, 2013
·
1 min read
Policy
Idenix Pharmaceuticals, Inc. Files Patent Infringement And Interference Lawsuits Against Gilead Sciences, Inc.
December 2, 2013
·
1 min read
